SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $33,120 | -58.6% | 36,032 | -22.2% | 0.00% | – |
Q3 2022 | $80,000 | -39.4% | 46,292 | -68.3% | 0.00% | – |
Q2 2022 | $132,000 | +22.2% | 146,008 | +299.6% | 0.00% | – |
Q1 2022 | $108,000 | -24.5% | 36,538 | +22.7% | 0.00% | – |
Q4 2021 | $143,000 | -51.4% | 29,788 | -66.7% | 0.00% | -100.0% |
Q3 2021 | $294,000 | -3.0% | 89,443 | +13.3% | 0.00% | 0.0% |
Q2 2021 | $303,000 | -4.1% | 78,952 | +122.2% | 0.00% | 0.0% |
Q1 2021 | $316,000 | +47.0% | 35,537 | +26.6% | 0.00% | 0.0% |
Q4 2020 | $215,000 | +83.8% | 28,078 | +89.0% | 0.00% | 0.0% |
Q3 2020 | $117,000 | -14.6% | 14,853 | -44.7% | 0.00% | 0.0% |
Q2 2020 | $137,000 | +185.4% | 26,845 | -27.4% | 0.00% | – |
Q1 2020 | $48,000 | +20.0% | 36,977 | -11.9% | 0.00% | – |
Q4 2019 | $40,000 | -60.0% | 41,977 | +116.4% | 0.00% | -100.0% |
Q1 2018 | $100,000 | -20.0% | 19,398 | -38.9% | 0.00% | 0.0% |
Q1 2017 | $125,000 | -19.4% | 31,730 | 0.0% | 0.00% | -50.0% |
Q4 2016 | $155,000 | -32.0% | 31,730 | +7.8% | 0.00% | -33.3% |
Q3 2016 | $228,000 | – | 29,430 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
B. Riley Financial, Inc. | 5,216,250 | $4,621,598 | 1.04% |
B. Riley Securities, Inc. | 5,216,250 | $4,621,598 | 1.00% |
EMFO, LLC | 209,398 | $185,527 | 0.19% |
Wellspring Financial Advisors, LLC | 483,551 | $428,426 | 0.14% |
Mayo Clinic | 300,000 | $267,000 | 0.14% |
swisspartners Ltd. | 110,000 | $97,465 | 0.12% |
Donald L. Hagan, LLC | 169,514 | $150,189 | 0.09% |
Oaktree Fund Advisors, LLC | 66,000 | $58,476 | 0.09% |
EUDAIMONIA ADVISORS LLC | 138,887 | $123,054 | 0.08% |
Asset Management Resources, LLC | 138,020 | $122,286 | 0.08% |